Average Co-Inventor Count = 5.40
ph-index = 28
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (641 from 3,217 patents)
2. Genetech, Inc. (22 from 98 patents)
3. University of California (6 from 15,410 patents)
4. The University of Melbourne (4 from 321 patents)
5. Central Sydney Area Health Service (2 from 11 patents)
6. Other (1 from 832,575 patents)
7. Genenetech, Inc. (1 from 1 patent)
8. Genentch, Inc. (1 from 1 patent)
667 patents:
1. RE46816 - Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
2. RE46805 - Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
3. RE46534 - Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
4. 8557238 - EG-VEGF nucleic acids and polypeptides and methods of use
5. 8455217 - Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof
6. 8431350 - Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
7. 8350008 - WISP polypeptides and nucleic acids encoding same
8. 8338132 - Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof
9. 8273703 - IL-17 receptor-like polypeptides and therapeutic uses thereof
10. 8178082 - Methods for up-regulating PAP1 in animals suffering from pancreatic disorders
11. 8106156 - PRO1120 polypeptides
12. 8097700 - TAT294 polypeptides
13. 8088386 - Treatment of complement-associated disorders
14. 8084200 - Compositions and methods for the diagnosis and treatment of tumor
15. 8075888 - Methods of treatment using antibodies to IL-17 homologous polypeptides